Back to Journals » International Journal of Nanomedicine » Volume 15

Finite Element Analysis for Predicting Skin Pharmacokinetics of Nano Transdermal Drug Delivery System Based on the Multilayer Geometry Model

Authors Gu Y, Gu Q, Yang Q, Yang M, Wang S, Liu J

Received 8 May 2020

Accepted for publication 30 July 2020

Published 12 August 2020 Volume 2020:15 Pages 6007—6018

DOI https://doi.org/10.2147/IJN.S261386

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Linlin Sun


Yongwei Gu,1– 3,* Qing Gu,4,* Qing Yang,1,2 Meng Yang,3 Shengzhang Wang,5 Jiyong Liu1– 3

1Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China; 3Department of Pharmacy, Changhai Hospital, Second Military Medical University, Shanghai 200433, People’s Republic of China; 4Department of Pharmacy, Jingan District Zhabei Central Hospital, Shanghai 200070, People’s Republic of China; 5Institute of Biomechanics, Department of Aeronautics and Astronautics, Fudan University, Shanghai 200433, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Shengzhang Wang
Department of Aeronautics and Astronautics, Institute of Biomechanics, Fudan University, Shanghai 200433, People’s Republic of China
Tel/Fax +86-21-65647825
Email szwang@fudan.edu.cn
Jiyong Liu
Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China
Tel/Fax +86-21-64175590
Email liujiyong@fudan.edu.cn

Background: Skin pharmacokinetics is an indispensable indication for studying the drug fate after administration of transdermal drug delivery systems (TDDS). However, the heterogeneity and complex skin structured with stratum corneum, viable epidermis, dermis, and subcutaneous tissue inevitably leads the drug diffusion coefficient (Kp) to vary depending on the skin depth, which seriously limits the development of TDDS pharmacokinetics in full thickness skin.
Methods: A multilayer geometry skin model was established and the Kp of drug in SC, viable epidermis, and dermis was obtained using the technologies of molecular dynamics simulation, in vitro permeation experiments, and in vivo microdialysis, respectively. Besides, finite element analysis (FEA) based on drug Kps in different skin layers was applied to simulate the paeonol nanoemulsion (PAE-NEs) percutaneous dynamic penetration process in two and three dimensions. In addition, PAE-NEs skin pharmacokinetics profile obtained by the simulation was verified by in vivo experiment.
Results: Coarse-grained modeling of molecular dynamic simulation was successfully established and the Kp of PAE in SC was 2.00× 10− 6 cm2/h. The Kp of PAE-NE in viable epidermis and in dermis detected using penetration test and microdialysis probe technology, was 1.58× 10− 5 cm2/h and 3.20× 10− 5 cm2/h, respectively. In addition, the results of verification indicated that PAE-NEs skin pharmacokinetics profile obtained by the simulation was consistent with that by in vivo experiment.
Discussion: This study demonstrated that the FEA combined with the established multilayer geometry skin model could accurately predict the skin pharmacokinetics of TDDS.

Keywords: nano transdermal drug delivery system, skin pharmacokinetics, finite element analysis, multilayer geometry model, diffusion coefficient, paeonol nanoemulsion

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]